Our platform: The Feldan Shuttle technology
Feldan Therapeutics has developed a protein-based technology platform, the Feldan Shuttle, for direct delivery of proteins inside cells. The platform has been successfully used on several cell types (including human primary cells which are the center of most cell-based therapeutic applications) and allowed the transfer of active nucleases, transcription factors and antibodies. This platform can overcome delivery obstacles in the context of therapeutic use by providing a safe and highly efficient approach that alleviates manipulation complexity and that is associated with low regulatory burden. Finally, preliminary results in rodents showed that the Feldan Shuttle could be potentially used as an in vivo delivery method.